Supplementary Tables 1 - 3 from Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma

Andrea Schuessler, Rajiv Khanna(QIMR Berghofer Medical Research Institute), Katherine Matthews, Kerenaftali Klein(QIMR Berghofer Medical Research Institute), Corey Smith(QIMR Berghofer Medical Research Institute), Tania Crough, Linda Jones, Hamish Alexander(Ankara Spine Center), Vijayendra Dasari(QIMR Berghofer Medical Research Institute), Glen M. Boyle(Queensland University of Technology), Amy Smalley(Wesley Hospital), Leone Beagley, David G. Walker, Sweera Rehan(QIMR Berghofer Medical Research Institute)
Unknown
March 30, 2023
10.1158/0008-5472.22403667
Cited by 0

Related Papers

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
|Nature|2011|474
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients
|Blood|2006|250
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
|Proceedings of the National Academy of Sciences|2004|235